Literature DB >> 7629296

Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B.

C M Chu1, Y F Liaw.   

Abstract

AIMS--To test the hypothesis that membranous staining of hepatitis B surface antigen (HBsAg) on the hepatocyte is a marker of active viral replication in chronic hepatitis B virus (HBV) infection. METHODS--Intrahepatic expression of HBsAg and hepatitis B core antigen (HBcAg) was studied by indirect immunofluorescence on frozen sections of liver specimens from 75 patients with chronic hepatitis B, and the results were correlated with serum levels of HBV-DNA assayed by spot hybridisation. RESULTS--Hepatocyte HBcAg was detected in all of 20 patients with serum levels of HBV-DNA > 1000 pg/ml, 18 (75%) of 24 patients with levels of HBV-DNA < or = 1000 pg/ml, and two (6.5%) of 31 patients without detectable serum HBV-DNA. The concordance between hepatocyte HBcAg and serum HBV-DNA was 89.3% (67/75). There were six patients (8%) who had detectable serum HBV-DNA but without hepatocyte HBcAg, and two patients (2.7%) who had detectable hepatocyte HBcAg but without serum HBV-DNA. Membranous staining of HBsAg associated with variable degrees of cytoplasmic HBsAg was found in all but one of 44 patients with serum HBV-DNA, irrespective of the levels, but in none of the 31 patients without serum HBV-DNA. Of the latter, HBsAg was distributed solely in the cytoplasm. In addition, there is an inverse correlation between serum levels of HBV-DNA and the degrees of cytoplasmic staining of HBsAg. The concordance between membranous staining fo HBsAg and serum HBV-DNA was 98.7% (74/75), significantly higher than that between hepatocyte HBcAG and serum HBV-DNA. CONCLUSIONS--Membranous staining of HBsAg on the hepatocyte correlated excellently with serum HBV-DNA and thus can be recognised as a sensitive and specific marker of active hepatitis B virus replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629296      PMCID: PMC502627          DOI: 10.1136/jcp.48.5.470

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Immunohistochemical localization of hepatitis B surface antigen and hepatitis B core antigen in tissue sections. A source of false positive staining.

Authors:  Z D Goodman; J M Langloss; G L Bratthauer; K Ishak
Journal:  Am J Clin Pathol       Date:  1988-04       Impact factor: 2.493

2.  Widespread presence of cytoplasmic HBcAg in hepatitis B infected liver detected by improved immunochemical methods.

Authors:  E J Gowans; C J Burrell
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

3.  Hepatitis B virus and polyalbumin binding sites.

Authors:  S N Thung; M A Gerber
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

4.  Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis.

Authors:  J Y Yoo; R Howard; J G Waggoner; J H Hoofnagle
Journal:  J Med Virol       Date:  1987-11       Impact factor: 2.327

5.  Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

Authors:  C M Chu; Y F Liaw
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

6.  Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.

Authors:  S J Hadziyannis; H M Lieberman; G G Karvountzis; D A Shafritz
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

7.  Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection.

Authors:  H C Hsu; I J Su; M Y Lai; D S Chen; M H Chang; S M Chuang; J L Sung
Journal:  J Hepatol       Date:  1987-08       Impact factor: 25.083

8.  Correlation between hepatic hepatitis B core antigen and serum hepatitis B virus-DNA levels in patients with chronic hepatitis B virus infections in Taiwan.

Authors:  J C Wu; S D Lee; J Y Wang; L P Ting; Y T Tsai; S H Tsay; M J Tong
Journal:  Arch Pathol Lab Med       Date:  1987-02       Impact factor: 5.534

9.  Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

Authors:  C M Chu; P Karayiannis; M J Fowler; J Monjardino; Y F Liaw; H C Thomas
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

10.  Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.

Authors:  P Karayiannis; M J Fowler; A S Lok; C Greenfield; J Monjardino; H C Thomas
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

View more
  13 in total

Review 1.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

Review 2.  Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.

Authors:  Sayed Shahabuddin Hoseini; Nai-Kong V Cheung
Journal:  Cancer Lett       Date:  2017-04-17       Impact factor: 8.679

3.  Associations of Expressions of HBcAg and HBsAg with the Histologic Activity of Liver Disease and Viral Replication.

Authors:  Myung Su Son; Jeong Hwan Yoo; Chang-Il Kwon; Kwang Hyun Ko; Sung Pyo Hong; Seong Gyu Hwang; Pil Won Park; Choong Kee Park; Kyu Sung Rim
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

4.  The degrees of hepatocyte nuclear but not cytoplasmic expression of hepatitis B core antigen reflect the level of viral replication in chronic hepatitis B virus infection.

Authors:  C M Chu; C T Yeh; R N Chien; I S Sheen; Y F Liaw
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  The degrees of hepatocyte cytoplasmic expression of hepatitis B core antigen correlate with histologic activity of liver disease in the young patients with chronic hepatitis B infection.

Authors:  Tae Hyeon Kim; Eun Young Cho; Hyo Jeong Oh; Chang Soo Choi; Ji Woong Kim; Heung Bae Moon; Haak Cheul Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

6.  Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.

Authors:  Parham Safaie; Mugilan Poongkunran; Ping-Ping Kuang; Asad Javaid; Carl Jacobs; Rebecca Pohlmann; Imad Nasser; Daryl T Y Lau
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

7.  Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

8.  HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice.

Authors:  Robert L Kruse; Thomas Shum; Haruko Tashiro; Mercedes Barzi; Zhongzhen Yi; Christina Whitten-Bauer; Xavier Legras; Beatrice Bissig-Choisat; Urtzi Garaigorta; Stephen Gottschalk; Karl-Dimiter Bissig
Journal:  Cytotherapy       Date:  2018-04-06       Impact factor: 5.414

9.  The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity.

Authors:  Fan Zou; Jizhou Tan; Ting Liu; Bingfeng Liu; Yaping Tang; Hui Zhang; Jiaping Li
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

10.  Can engineered "designer" T cells outsmart chronic hepatitis B?

Authors:  U Protzer; H Abken
Journal:  Hepat Res Treat       Date:  2010-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.